ISEE stock forecast
Our latest prediction for IVERIC bio, Inc.'s stock price was made on the Dec. 10, 2019 when the stock price was at 5.41$.
In the short term (2weeks), ISEE's stock price should underperform the market by -4.46%. During that period the price should oscillate between -11.95% and +15.49%.
In the medium term (3months), ISEE's stock price should underperform the market by -13.70%. During that period the price should oscillate between -28.85% and +21.49%.Get email alerts
About IVERIC bio, Inc.
IVERIC bio, Inc. is a biopharmaceutical company which engages in discovering, developing, and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in New York, NY.
At the moment the company generates 210M USD in revenues.
On its last earning announcement, the company reported a profit of 1.83$ per share.
The book value per share is 2.75$
Three months stock forecastDec. 10, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|